UK, are you watching?
An outbreak of meningitis B in US Ivy League Princeton University has the CDC clamouring for the Bexsero vaccine – even before it’s been approved by the FDA.
Back in July, despite European approval, Novartis’ Bexsero jab was shunned by the UK’s Joint Committee on Vaccination and Immunisation (JCVI), who recommended that the vaccine was unlikely to be cost effective at any price level.
Now across the Atlantic, Princeton University student have been in the grip of a meningitis B outbreak that’s recently recorded its seventh case. The CDC has since requested and received permission from the FDA to import the emergency vaccine, and Princeton’s trustees are deliberating whether to embark on a campuswide campaign with vaccine.
"It probably takes one to two months until vaccination could start" at Princeton, said Andrin Oswald, head of Novartis vaccines and diagnostics.
Regarding the decision of the JCVI in July not to recommend the vaccine for the UK, Sue Davie, the chief executive of the Meningitis Trust and Meningitis UK, said: "This is extremely disappointing news after all our supporters and our hard work over decades to introduce a vaccine. We understand the committee's concerns about impact and cost, but we believe this vaccine is safe and we know it will save lives. The more we delay the more lives are being lost."
Read more at Bloomberg >